Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lotus Pharmaceutical Co Ltd gets FDA approval for Mefenamic Acid (250mg Capsule)

Monday, 4 Aug 2014 05:42am EDT 

Lotus Pharmaceutical Co Ltd:Got Food and Drug Administration approval for its new drug Mefenamic Acid (250mg Capsule) and to begin selling in August. 

Company Quote

-0.4 -0.42%
28 Jan 2015